Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Research Report 2020
Table of Contents1 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Overview
1.1 Product Overview and Scope of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)
1.2 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Segment by Type
1.2.1 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Control Hyperphosphatemia
1.2.3 Maintain Blood Calcium Levels
1.2.4 Control PTH Level
1.2.5 Correct Acidosis
1.2.6 Other
1.3 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Segment by Application
1.3.1 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Comparison by Application: (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.3.6 Other
1.4 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Size Estimates and Forecasts
1.4.1 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue 2015-2026
1.4.2 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales 2015-2026
1.4.3 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2020 Versus 2026
2 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Competition by Manufacturers
2.1 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2015-2020)
2.3 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Manufacturing Sites, Area Served, Product Type
2.5 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Competitive Situation and Trends
2.5.1 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Players (Opinion Leaders)
3 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario by Region
3.1 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.3.1 North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.3.2 North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.4.1 Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.4.2 Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Region
3.5.1 Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Region
3.5.2 Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.6.1 Latin America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.6.2 Latin America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.7.1 Middle East and Africa Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.7.2 Middle East and Africa Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Historic Market Analysis by Type
4.1 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
4.2 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2015-2020)
4.3 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Price Market Share by Type (2015-2020)
4.4 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Historic Market Analysis by Application
5.1 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
5.2 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2015-2020)
5.3 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Business
6.1 Akebia
6.1.1 Corporation Information
6.1.2 Akebia Description, Business Overview
6.1.3 Akebia Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Akebia Products Offered
6.1.5 Akebia Recent Development
6.2 Astellas
6.2.1 Astellas Corporation Information
6.2.2 Astellas Description, Business Overview
6.2.3 Astellas Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Astellas Products Offered
6.2.5 Astellas Recent Development
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description, Business Overview
6.3.3 Takeda Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Takeda Products Offered
6.3.5 Takeda Recent Development
6.4 Vifor
6.4.1 Vifor Corporation Information
6.4.2 Vifor Description, Business Overview
6.4.3 Vifor Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Vifor Products Offered
6.4.5 Vifor Recent Development
6.5 Abbvie
6.5.1 Abbvie Corporation Information
6.5.2 Abbvie Description, Business Overview
6.5.3 Abbvie Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Abbvie Products Offered
6.5.5 Abbvie Recent Development
6.6 Fresenius
6.6.1 Fresenius Corporation Information
6.6.2 Fresenius Description, Business Overview
6.6.3 Fresenius Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Fresenius Products Offered
6.6.5 Fresenius Recent Development
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description, Business Overview
6.6.3 Abbott Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Abbott Products Offered
6.7.5 Abbott Recent Development
6.8 Novadiol
6.8.1 Novadiol Corporation Information
6.8.2 Novadiol Description, Business Overview
6.8.3 Novadiol Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Novadiol Products Offered
6.8.5 Novadiol Recent Development
6.9 Japan Tobacco Company
6.9.1 Japan Tobacco Company Corporation Information
6.9.2 Japan Tobacco Company Description, Business Overview
6.9.3 Japan Tobacco Company Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Japan Tobacco Company Products Offered
6.9.5 Japan Tobacco Company Recent Development
6.10 Daiichi-Sankyo
6.10.1 Daiichi-Sankyo Corporation Information
6.10.2 Daiichi-Sankyo Description, Business Overview
6.10.3 Daiichi-Sankyo Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Daiichi-Sankyo Products Offered
6.10.5 Daiichi-Sankyo Recent Development
6.11 Shield
6.11.1 Shield Corporation Information
6.11.2 Shield Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Description, Business Overview
6.11.3 Shield Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Shield Products Offered
6.11.5 Shield Recent Development
6.12 Spectrum
6.12.1 Spectrum Corporation Information
6.12.2 Spectrum Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Description, Business Overview
6.12.3 Spectrum Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Spectrum Products Offered
6.12.5 Spectrum Recent Development
6.13 OPKO
6.13.1 OPKO Corporation Information
6.13.2 OPKO Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Description, Business Overview
6.13.3 OPKO Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 OPKO Products Offered
6.13.5 OPKO Recent Development
6.14 Ardelyx
6.14.1 Ardelyx Corporation Information
6.14.2 Ardelyx Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Description, Business Overview
6.14.3 Ardelyx Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Ardelyx Products Offered
6.14.5 Ardelyx Recent Development
6.15 Sanofi Genzyme
6.15.1 Sanofi Genzyme Corporation Information
6.15.2 Sanofi Genzyme Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Description, Business Overview
6.15.3 Sanofi Genzyme Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Sanofi Genzyme Products Offered
6.15.5 Sanofi Genzyme Recent Development
6.16 Amgen
6.16.1 Amgen Corporation Information
6.16.2 Amgen Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Description, Business Overview
6.16.3 Amgen Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Amgen Products Offered
6.16.5 Amgen Recent Development
7 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Manufacturing Cost Analysis
7.1 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)
7.4 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Distributors List
8.3 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) by Type (2021-2026)
10.2 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) by Application (2021-2026)
10.3 Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Manufacturers Covered in This Study
Table 5. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturers (2015-2020)
Table 7. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Sites and Area Served
Table 11. Manufacturers Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Product Types
Table 12. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Players
Table 16. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Region (2015-2020)
Table 17. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2015-2020)
Table 18. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2015-2020)
Table 20. North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 21. North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 22. North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 24. Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 25. Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 26. Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 33. Latin America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 34. Latin America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 40. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Type (2015-2020)
Table 41. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Share by Type (2015-2020)
Table 42. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Share by Type (2015-2020)
Table 44. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Type (2015-2020)
Table 45. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Application (2015-2020)
Table 46. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 47. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Application (2015-2020)
Table 48. Akebia Corporation Information
Table 49. Akebia Description and Business Overview
Table 50. Akebia Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. Akebia Main Product
Table 52. Akebia Recent Development
Table 53. Astellas Corporation Information
Table 54. Astellas Description and Business Overview
Table 55. Astellas Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Astellas Main Product
Table 57. Astellas Recent Development
Table 58. Takeda Corporation Information
Table 59. Takeda Description and Business Overview
Table 60. Takeda Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Takeda Main Product
Table 62. Takeda Recent Development
Table 63. Vifor Corporation Information
Table 64. Vifor Description and Business Overview
Table 65. Vifor Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Vifor Main Product
Table 67. Vifor Recent Development
Table 68. Abbvie Corporation Information
Table 69. Abbvie Description and Business Overview
Table 70. Abbvie Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Abbvie Main Product
Table 72. Abbvie Recent Development
Table 73. Fresenius Corporation Information
Table 74. Fresenius Description and Business Overview
Table 75. Fresenius Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Fresenius Main Product
Table 77. Fresenius Recent Development
Table 78. Abbott Corporation Information
Table 79. Abbott Description and Business Overview
Table 80. Abbott Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Abbott Main Product
Table 82. Abbott Recent Development
Table 83. Novadiol Corporation Information
Table 84. Novadiol Description and Business Overview
Table 85. Novadiol Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Novadiol Main Product
Table 87. Novadiol Recent Development
Table 88. Japan Tobacco Company Corporation Information
Table 89. Japan Tobacco Company Description and Business Overview
Table 90. Japan Tobacco Company Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Japan Tobacco Company Main Product
Table 92. Japan Tobacco Company Recent Development
Table 93. Daiichi-Sankyo Corporation Information
Table 94. Daiichi-Sankyo Description and Business Overview
Table 95. Daiichi-Sankyo Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Daiichi-Sankyo Main Product
Table 97. Daiichi-Sankyo Recent Development
Table 98. Shield Corporation Information
Table 99. Shield Description and Business Overview
Table 100. Shield Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. Shield Main Product
Table 102. Shield Recent Development
Table 103. Spectrum Corporation Information
Table 104. Spectrum Description and Business Overview
Table 105. Spectrum Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Spectrum Main Product
Table 107. Spectrum Recent Development
Table 108. OPKO Corporation Information
Table 109. OPKO Description and Business Overview
Table 110. OPKO Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. OPKO Main Product
Table 112. OPKO Recent Development
Table 113. Ardelyx Corporation Information
Table 114. Ardelyx Description and Business Overview
Table 115. Ardelyx Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. Ardelyx Main Product
Table 117. Ardelyx Recent Development
Table 118. Sanofi Genzyme Corporation Information
Table 119. Sanofi Genzyme Description and Business Overview
Table 120. Sanofi Genzyme Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 121. Sanofi Genzyme Main Product
Table 122. Sanofi Genzyme Recent Development
Table 123. Amgen Corporation Information
Table 124. Amgen Description and Business Overview
Table 125. Amgen Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 126. Amgen Main Product
Table 127. Amgen Recent Development
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 131. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Customers List
Table 132. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Trends
Table 133. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Opportunities and Drivers
Table 134. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Challenges
Table 135. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) Forecast by Type (2021-2026)
Table 136. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Type (2021-2026)
Table 137. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue (Million US$) Forecast by Type (2021-2026)
Table 138. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 139. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) Forecast by Application (2021-2026)
Table 140. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue (Million US$) Forecast by Application (2021-2026)
Table 141. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales (MT) Forecast by Region (2021-2026)
Table 142. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of FiguresFigure 1. Picture of Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)
Figure 2. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type: 2020 VS 2026
Figure 3. Control Hyperphosphatemia Product Picture
Figure 4. Maintain Blood Calcium Levels Product Picture
Figure 5. Control PTH Level Product Picture
Figure 6. Correct Acidosis Product Picture
Figure 7. Other Product Picture
Figure 8. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Consumption Market Share by Application: 2020 VS 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Drug Stores
Figure 13. Other
Figure 14. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Size 2015-2026 (US$ Million)
Figure 15. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Capacity (MT) (2015-2026)
Figure 16. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturers in 2020
Figure 18. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers in 2019
Figure 19. The Global 5 and 10 Largest Players: Market Share by Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue in 2019
Figure 20. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2015-2020)
Figure 22. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2019
Figure 23. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2015-2020)
Figure 24. Global Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region in 2019
Figure 25. North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 26. North America Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 27. U.S. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 28. U.S. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Canada Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 30. Canada Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 32. Europe Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 33. Germany Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 34. Germany Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. France Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 36. France Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. U.K. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 38. U.K. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Italy Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 40. Italy Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Russia Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 42. Russia Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2019
Figure 44. Asia Pacific Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region in 2019
Figure 45. China Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 46. China Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Japan Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 48. Japan Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. South Korea Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 50. South Korea Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. India Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 52. India Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Australia Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 54. Australia Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Taiwan Chronic Kidney Disease-Mineral and Bone Disorde